Education
About Us
Working with TipRanks
Follow Us
Love Pharma Inc (TSE:JOLT)
:JOLT
JOLT Stock Chart & Stats
C$0.08
C$0.00(0.00%)
At close: 4:00 PM EDT
C$0.08
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.05 - C$0.15
Previous CloseN/A
Volume0.00
Average Volume (3M)3.18K
Market Cap
C$1.08M
Enterprise ValueC$670.74K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-2.76
Next Earnings
Apr 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding12,728,754
10 Day Avg. Volume6,475
30 Day Avg. Volume3,183
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Love Pharma Inc News
JOLT FAQ
What was Love Pharma Inc’s price range in the past 12 months?
Love Pharma Inc lowest stock price was C$0.04 and its highest was C$0.15 in the past 12 months.
What is Love Pharma Inc’s market cap?
Love Pharma Inc’s market cap is C$1.08M.
When is Love Pharma Inc’s upcoming earnings report date?
Love Pharma Inc’s upcoming earnings report date is Apr 30, 2026 which is in 125 days.
How were Love Pharma Inc’s earnings last quarter?
Love Pharma Inc released its earnings results on Dec 01, 2025. The company reported -C$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.008.
Is Love Pharma Inc overvalued?
According to Wall Street analysts Love Pharma Inc’s price is currently Overvalued.
Does Love Pharma Inc pay dividends?
Love Pharma Inc does not currently pay dividends.
What is Love Pharma Inc’s EPS estimate?
Love Pharma Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Love Pharma Inc have?
Love Pharma Inc has 12,728,754 shares outstanding.
What happened to Love Pharma Inc’s price movement after its last earnings report?
Love Pharma Inc reported an EPS of -C$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Love Pharma Inc?
Currently, no hedge funds are holding shares in TSE:JOLT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Love Pharma Inc
Glenbriar Technologies Inc offers cloud-enabled business technology solutions in Canada. The company operates through the Information Technology segment. It provides business technology solutions in manufacturing, distribution, retail, energy, health, professional services, and real estate. The company also provides IT outsourcing and consulting services. It derives the majority of its revenue from Managed information services.
Technical Analysis
Genix Pharmaceuticals
―
Mydecine Innovations Group
―
NeutriSci International
―
Lumiera Health Inc
―
NAVCO Pharmaceuticals Inc
―
Options Prices
Currently, No data available
---